Cargando…

Progresses in clinical studies on antiviral therapies for COVID‐19—Experience and lessons in design of clinical trials

Antiviral therapy with antiviral agents is a very important component of treatment for the 2019 novel coronavirus disease (COVID‐19) caused by the severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2). It is important to clarify how to evaluate efficacy and safety of antiviral agents in treat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhaori, Getu, Lu, Lu, Liu, Chunyan, Guo, Yongli
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7768300/ https://www.ncbi.nlm.nih.gov/pubmed/33376954 http://dx.doi.org/10.1002/ped4.12227

Ejemplares similares

Better design leads to better results – Importance of virological outcome design in clinical trials for antiviral treatment of coronavirus disease 2019
por: Zhaori, Getu, et al.
Publicado: (2023)

Further standardization and safety issues for antiviral therapy during pregnancy
por: Zhaori, Getu
Publicado: (2020)

A new column in this journal – Forum on Clinical Investigation
por: Zhaori, Getu
Publicado: (2023)

Potential clinical application of RNAi‐based therapeutic strategies for treatment of chronic hepatitis B
por: Zhaori, Getu
Publicado: (2018)

Smoke evacuation, is it important for prevention of COVID‐19?
por: Zhaori, Getu
Publicado: (2020)

Nirsevimab brings breakthrough in the prevention of respiratory syncytial virus infection in infants – Importance of design
por: Zhaori, Getu
Publicado: (2023)

RNAi technique, how far is it from pediatrics?
por: Zhaori, Getu
Publicado: (2017)

Old problem may have new solution
por: Zhaori, Getu
Publicado: (2018)

Pediatric Investigation, what differences can it make?
por: Zhaori, Getu
Publicado: (2017)

Chylothorax in infants and children in China, a very good start
por: Zhaori, Getu
Publicado: (2018)

Professor Robert Freedman and his contributions to psychiatric research
por: Zhaori, Getu
Publicado: (2020)

Severe acute hepatitis of unknown causes in children – Current findings, questions, opinions, and recommendations, a mini‐review
por: Zhaori, Getu
Publicado: (2022)

Congenital chylothorax: Rare disease, wide concern
por: Shen, Kunling, et al.
Publicado: (2017)

Collaborative studies of U.S.–China neurologists on acute motor axonal neuropathy
por: Lv, Junlan, et al.
Publicado: (2022)

Study Design Characteristics and Pharmacological Mechanisms in International Clinical Trials Registry Platform: Registered Clinical Trials on Antiviral Drugs for COVID-19
por: Zhang, Weilong, et al.
Publicado: (2020)

Gastric cancer metastasis-related NT5DC2 indicates unfavorable prognosis of patients
por: Sha, Rula, et al.
Publicado: (2023)

Emerging clinical trial designs may accelerate translation in hematology: lessons from COVID-19
por: Neal, Matthew D., et al.
Publicado: (2022)

Advancing Clostridia to Clinical Trial: Past Lessons and Recent Progress
por: Mowday, Alexandra M., et al.
Publicado: (2016)

Designing and Implementing “Living and Breathing” Clinical Trials: An Overview and Lessons Learned from the COVID-19 Pandemic
por: Horvat, Christopher M., et al.
Publicado: (2023)

Cancer gene therapy clinical trials: lessons for the future
por: Galanis, E, et al.
Publicado: (2001)

Future antiviral surfaces: Lessons from COVID-19 pandemic
por: Sun, Ziqi, et al.
Publicado: (2020)

Efficacy of repurposed antiviral drugs: Lessons from COVID-19
por: Martinez, Miguel Angel
Publicado: (2022)

Accelerating antiviral drug discovery: lessons from COVID-19
por: von Delft, Annette, et al.
Publicado: (2023)

Perspective Adjunctive Therapies for COVID-19: Beyond Antiviral Therapy
por: Ho, Ping, et al.
Publicado: (2021)

Characteristics analysis for clinical study design relating to COVID-19 based on the database of ClinicalTrials.gov
por: Wu, Hanting, et al.
Publicado: (2022)

Antiviral therapy for COVID-19: Derivation of optimal strategy based on past antiviral and favipiravir experiences
por: Shiraki, Kimiyasu, et al.
Publicado: (2022)

Large scale clinical trials: lessons from the COVID-19 pandemic
por: Horsley, Alex R, et al.
Publicado: (2022)

Failures in Clinical Trials in the European Union: Lessons from the Polish Experience
por: Waligora, Marcin
Publicado: (2012)

Resilient Clinical Trial Infrastructure in Response to the COVID-19 Pandemic: Lessons Learned from the TOGETHER Randomized Platform Clinical Trial
por: Forrest, Jamie I., et al.
Publicado: (2022)

Authorization of COVID-19 clinical trials: lessons from 2 years of experience of a national competent authority
por: Vignot, Stéphane, et al.
Publicado: (2022)

Process Evaluation of an Implementation Trial: Design, Rationale, and Early Lessons Learnt From an International Cluster Clinical Trial in Intracerebral Hemorrhage
por: Ouyang, Menglu, et al.
Publicado: (2022)

The Design of Clinical Trials in Cancer Therapy
por: Todd, I. D. H.
Publicado: (1972)

Antiviral Agent Therapy Optimization in Special Populations of COVID-19 Patients
por: Li, Lu, et al.
Publicado: (2020)

Stroke recovery enhancing therapies: lessons from recent clinical trials
por: Rogalewski, Andreas, et al.
Publicado: (2021)

Stem Cell Therapies in Movement Disorders: Lessons from Clinical Trials
por: Marsili, Luca, et al.
Publicado: (2023)

Antiviral Therapy of COVID-19
por: Gudima, Georgii, et al.
Publicado: (2023)

Evaluating Clinical Efficacy of Antiviral Therapy for COVID-19: A Surrogate Endpoint Approach
por: Jen, Hsiao-Hsuan, et al.
Publicado: (2021)

Phage therapy for pulmonary infections: lessons from clinical experiences and key considerations
por: Mitropoulou, Georgia, et al.
Publicado: (2022)

Antiviral Effects of Ivermectin in COVID-19- Clinically Plausible?
por: Shukla, Dr. Ajay Kumar, et al.
Publicado: (2021)

Exploiting natural antiviral immunity for the control of pandemics: Lessons from Covid-19
por: Aricò, Eleonora, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_l2tg321idmp0mhn1683k6smhp0